Heart attack diagnostics are mainly related to indications like chest pain. It leads to a heart attack when the blood flow gets blocked to your heart and oxygen imbalance takes place. The cases of chronic diseases, such as hypertension and diabetes are rising in the population. Several risk factors like high body mass index, shift towards unhealthy lifestyle, tobacco smoking will narrow the coronary arteries and result in atherosclerosis because of fat deposition and high cholesterol level
COVID-19 Impact analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
At the early phase of COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis. Owing to such factors, COVID 19 is expected to have a significant impact on the heart attack diagnostics market.
Top Impacting Factors
- Increase in cases of coronary heart diseases, technological advancements in ECG devices such as handheld and portable, surge in geriatric populations, rising obesity and tobacco smoking, shift towards unhealthy lifestyle, favorable government regulations regarding monitoring devices are factors that drive the growth of heart attack diagnostics market.
- In addition, increase in healthcare expenditure; collaborations & partnerships between key players to facilitate drug development; rise in R&D activities; launch of novel devices; and technological development are some factors, which boost the market growth for heart attack diagnostics.
- However, higher cost of diagnostic products, lack of skilled professional and, Low Medicare reimbursement provided for the mobile cardiac outpatient telemetry electrocardiogram (ECG) will hinder the heart attack diagnostics market growth.
Heart Attack Diagnostics Market Trends
New product launches to flourish the market
In September 2018, Abbott received CE Mark for its High Sensitive Troponin-I blood test. This test assists in predicting the heart attack risk in healthy adults.
In May 2019, RX Implantable Cardiac Monitor (ICM) was launched by Abbott. This monitor observes the heartbeat to track heart rhythm.
Surge in usage in cardiovascular treatment
The growing cases of cardiovascular diseases, increase in aging populations, rising demand for advance cardiovascular treatment will drive the growth of heart attack diagnostics market. Additionally, expanding healthcare expenditure, collaborations and partnerships between key players, increasing R & D, launches of novel developed devices and technological developments are some factors which upsurge the market growth of heart attack diagnostics market.
Key Benefits of the Report
- This study presents the analytical depiction of the heart attack diagnostics industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the heart attack diagnostics market share.
- The current market is quantitatively analyzed to highlight the heart attack diagnostics market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the heart attack diagnostics market.
- The report provides a detailed heart attack diagnostics market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the heart attack diagnostics market Report
- Which are the leading players active in the heart attack diagnostics market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is "Heart attack diagnostics "?
- What is "Heart attack diagnostics" Market prediction in the future?
- Who are the leading global players in the "Heart attack diagnostics" Market?
- What are the current trends and predicted trends?
- What are the key benefits of the "Heart attack diagnostics" Market report?
Heart Attack Diagnostics Market Report Highlights
| Aspects | Details |
 By Test Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | F. Hoffmann-La Roche Ltd., Welch Allyn, Inc., Abbott Laboratories, Toshiba Corporation, GE Healthcare, Schiller AG, Hitachi Medical Systems, Bionet Co., Ltd., Life Sign LLC, Bio-Rad Laboratories Inc., Koninklijke Philips N.V., Beckman Coulter, Siemens Healthcare Diagnostics, Midmark Corporation |
Loading Table Of Content...
